Loading CPT…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("CPT","financials")Full statements spill as a table. For one cell: =jivedata("CPT","Revenue") or =jivedata("CPT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
CPT • CIK 0000906345
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 1,000,000 | 1,800,000 | 1,800,000 | 1,800,000 |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $403,309 | $163,293 | $384,462 | $326,209 |
| Participating Securities, Distributed and Undistributed Earnings (Loss), Basic | $646 | $295 | $824 | $694 |
| Net Income (Loss) Available to Common Stockholders, Basic | $402,663 | $162,998 | $383,638 | $325,515 |
| Weighted Average Number of Shares Outstanding, Basic | 108,653,000 | 108,491,000 | 108,376,000 | 103,369,000 |
| Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities | $2,086 | $0 | $0 | $0 |
| Net Income (Loss) Available to Common Stockholders, Diluted | $404,749 | $162,998 | $383,638 | $325,515 |
| Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock | 725,000 | 0 | 0 | 0 |
| Weighted Average Number of Shares Outstanding, Diluted | 109,399,000 | 108,539,000 | 108,434,000 | 103,422,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Liabilities and Equity | $9,383,737 | $8,852,144 | $9,042,989 | $9,456,080 |
| Land | $1,711,873 | $1,722,526 | $1,787,445 | $1,695,652 |
| Investment Building and Building Improvements | $10,993,390 | $11,319,460 | $11,792,960 | $11,271,829 |
| Real Estate Investment Property, Accumulated Depreciation | $4,332,524 | $4,867,422 | $5,296,061 | $5,014,551 |
| Other Assets | $244,182 | $234,838 | $293,292 | $314,199 |
| Cash and Cash Equivalents, at Carrying Value | $259,686 | $21,045 | $25,203 | $44,717 |
| Restricted Cash and Cash Equivalents | $8,361 | $11,164 | $12,039 | $10,717 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $71,014 | $71,991 | $75,730 | $76,191 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $5,051,771 | $4,747,189 | $4,438,253 | $3,878,315 |
| Unsecured Debt | $3,385,309 | $3,155,233 | $3,570,193 | $4,529,573 |
| Secured Debt | $330,127 | $330,358 | $330,597 | $318,755 |
| Accounts Payable and Accrued Liabilities | $222,599 | $215,179 | $248,087 | $248,434 |
| Accrual for Taxes Other than Income Taxes | $96,517 | $78,529 | $92,382 | $99,264 |
| Other Liabilities | $186,987 | $212,107 | $248,506 | $264,968 |
| Liabilities | $4,331,966 | $4,104,955 | $4,604,736 | $5,577,765 |
| Additional Paid in Capital, Common Stock | $5,914,868 | $5,930,729 | $5,948,938 | $5,953,409 |
| Accumulated Distributions in Excess of Net Income | $613,651 | $897,931 | $969,240 | $1,127,157 |
| Treasury Stock, Value | $320,364 | $359,732 | $620,497 | $1,028,058 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-1,252 | $974 | $2,165 | $2,773 |
| Stockholders' Equity Attributable to Parent | $4,980,757 | $4,675,198 | $4,362,523 | $3,802,124 |
| Common Stock, Shares Authorized | 175,000,000 | 175,000,000 | 175,000,000 | 175,000,000 |
| Common Stock, Shares, Issued | 117,737,712 | 117,737,740 | 117,737,767 | 117,737,779 |
| Treasury Stock, Common, Shares | 8,859,556 | 9,091,081 | 11,373,251 | 15,191,591 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $410,553 | $170,840 | $394,898 | $336,617 |
| Net Cash Provided by (Used in) Operating Activities | $794,950 | $774,877 | $826,621 | $807,444 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $250,609 | $-235,838 | $5,033 | $14,175 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $268,047 | $32,209 | $37,242 | $129,747 |
| Depreciation, Depletion and Amortization | $574,813 | $582,014 | $611,025 | $616,799 |
| Payments to Develop Real Estate Assets | $410,934 | $393,735 | $440,402 | $485,125 |
| Gain (Loss) on Extinguishment of Debt | $-2,513 | $-921 | $0 | $0 |
| Payments to Acquire Real Estate | $0 | $0 | $419,226 | $531,494 |
| Gain (Loss) on Disposition of Assets | $225,416 | $43,806 | $260,910 | $281,717 |
| Asset Impairment Charges | — | $40,988 | $12,916 | $12,916 |
| Payments to Acquire Other Property, Plant, and Equipment | $5,597 | $3,800 | $2,445 | $2,445 |
| Share-based Payment Arrangement, Noncash Expense | $14,512 | $15,166 | $16,959 | $16,835 |
| Payments for (Proceeds from) Other Investing Activities | $1,259 | $2,169 | $3,372 | $9,606 |
| Other Operating Activities, Cash Flow Statement | $17,975 | $8,754 | $51,733 | $101,139 |
| Net Cash Provided by (Used in) Investing Activities | $-127,127 | $-285,230 | $-499,539 | $-644,845 |
| Proceeds from Lines of Credit | $1,335,000 | $586,000 | $588,000 | $864,000 |
| Repayments of Lines of Credit | $1,377,000 | $408,000 | $766,000 | $507,000 |
| Proceeds from (Repayments of) Commercial Paper | — | — | $588,108 | $82,018 |
| Repayments of Notes Payable | $437,749 | $800,000 | $0 | $11,950 |
| Proceeds from Notes Payable | $498,235 | $395,952 | $0 | $595,716 |
| Payments of Dividends | $434,875 | $450,965 | $460,950 | $458,536 |
| Payments of Financing Costs | $3,114 | $2,878 | $2,386 | $11,642 |
| Payments for Repurchase of Common Stock | — | $49,997 | $270,654 | $703,702 |
| Proceeds from (Payments for) Other Financing Activities | $2,289 | $4,403 | $1,833 | $4,149 |
| Net Cash Provided by (Used in) Financing Activities | $-417,214 | $-725,485 | $-322,049 | $-148,424 |
| Cash and Cash Equivalents, at Carrying Value | $259,686 | $21,045 | $25,203 | $39,705 |
| Restricted Cash and Cash Equivalents | $8,361 | $11,164 | $12,039 | $90,042 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $128,870 | $129,637 | $139,625 | $137,179 |
| Income Taxes Paid | $3,591 | $2,816 | $3,482 | $4,919 |
| Dividends | $110,427 | $113,549 | $114,971 | $109,353 |
| Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | $24,850 | $25,134 | $27,542 | $24,888 |
| Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | — | — | $22,005 | $22,005 |
| Increase (Decrease) in Other Operating Assets | $1,951 | $8,731 | $-3,449 | $-37,528 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $13,639 | $-3,336 | $18,293 | $31,809 |
| Increase (Decrease) in Property and Other Taxes Payable | $968 | $-17,776 | $17,646 | $9,751 |
| Increase (Decrease) in Other Operating Liabilities | $2,018 | $34,717 | $6,879 | $15,896 |
| Other Noncash Income (Expense) | $-3,301 | $-3,880 | $-5,466 | $-6,155 |